Trials / Completed
CompletedNCT05526404
Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration
Mobile Application Based Lactulose Titration for Prevention of Hepatic Encephalopathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to assess the safety and efficacy of using mobile application-based Bristol stool scale to titrate lactulose in prevention episodes of hepatic encephalopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dieta mobile application | Mobile application that functions on mobile phones and allows for tracking of symptoms, dietary intake, and stool characteristics using logs and pictures. Users of the application track symptoms by completing questionnaires regarding stool frequency, consistency, and mental status changes. Users can track dietary intake and stool characteristics by taking time-stamped photos of all dietary intake and bowel movements. |
Timeline
- Start date
- 2022-09-14
- Primary completion
- 2023-07-08
- Completion
- 2023-07-08
- First posted
- 2022-09-02
- Last updated
- 2023-08-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05526404. Inclusion in this directory is not an endorsement.